Physician profile
Frederick Nunnally
NPI 1689636086
$2,112.16
in general payments reported to CMS, 2019-2025
14 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $340 · 2021: $186 · 2022: $581 · 2023: $214 · 2024: $353 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782 · Education: $90.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.73 |
| Education | $90.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $708.06 | 2021-2025 | |
| Medical Device Business Services, INC. | $382.49 | 2022 | |
| Aerin Medical INC. | $269.47 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $242.72 | 2020-2025 | Dupixent |
| Optinose US, INC. | $195.55 | 2019-2021 | |
| Abbvie INC. | $69.83 | 2023 | |
| Acclarent, INC | $55.05 | 2021-2022 | |
| Glaxosmithkline, LLC. | $41.20 | 2024-2025 | Nucala |
| Amgen INC. | $34.00 | 2025 | |
| Merck Sharp & Dohme LLC | $33.43 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $26.82 | 2023 | Exparel |
| Stryker Corporation | $22.44 | 2019 | |
| Medtronic USA, INC. | $17.89 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Nunnally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.